No data to show
OTCM
MDCN
Market cap28kUSD
Jul 21, Last price
0.00USD
1D
-99.00%
1Q
0.00%
Jan 2017
-99.00%
IPO
-100.00%
Name
Medican Enterprises Inc
Chart & Performance
P/E
0.04
P/S
—
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
675k
CFO
Profile
Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY |
|---|---|
| 2023‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | 675 |
Tax Rate | |
NOPAT | (675) |
Net income | 675 |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | 38,944,976 |
Price | 0.00 |
Market cap | 39 |
EV | 39 |
EBITDA | |
EV/EBITDA | |
Interest | 925 |
Interest/NOPBT | |